Van Besien, Koen

Publications

Sort by

Co-Author Network

selected publications

Reply to Caldwell et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Academic Article GET IT
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 4
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone marrow transplantation. 2022 Letter GET IT
Times cited: 3
Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience. Journal of immunotherapy (Hagerstown, Md. : 1997). 2022 Academic Article GET IT
Times cited: 4
Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!. Leukemia & lymphoma. 2021 Comment GET IT
Times cited: 1
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults. Leukemia & lymphoma. 2021 Letter GET IT
Times cited: 2
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leukemia & lymphoma. 2021 Academic Article GET IT
Times cited: 1
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Academic Article GET IT
Times cited: 15
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy. Transplantation and cellular therapy. 2021 Academic Article GET IT
Times cited: 1
Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectations. Leukemia & lymphoma. 2021 Academic Article GET IT
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia. NPJ precision oncology. 2021 Academic Article GET IT
Times cited: 224
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma. Leukemia & lymphoma. 2021 Academic Article GET IT
Is less more? Viewpoint on empiric vancomycin therapy of fever and neutropenia after allogeneic stem cell transplantation. Leukemia & lymphoma. 2020 Comment GET IT
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma. JAMA oncology. 2020 Letter GET IT
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma. Journal for immunotherapy of cancer. 2020 Academic Article GET IT
Times cited: 8
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response. Blood advances. 2020 Academic Article GET IT
Times cited: 4
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Academic Article GET IT
Times cited: 8
Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?. Leukemia & lymphoma. 2020 Comment GET IT
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clinical and experimental immunology. 2020 Academic Article GET IT
Times cited: 32
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic. CA: a cancer journal for clinicians. 2020 Academic Article GET IT
Times cited: 12
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 2020 Letter GET IT
Times cited: 2
Hematological manifestations of COVID-19. Leukemia & lymphoma. 2020 Review GET IT
Times cited: 17
Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir. Transplant infectious disease : an official journal of the Transplantation Society. 2020 Academic Article GET IT
Times cited: 3
Cord blood transplants supported by unrelated donor CD34⁺ progenitor cells. Bone marrow transplantation. 2020 Academic Article GET IT
Times cited: 3
Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?. Leukemia & lymphoma. 2020 Comment GET IT
Times cited: 1
An update on options of therapy for aggressive mantle cell lymphoma. Leukemia & lymphoma. 2020 Review GET IT
Times cited: 1
Alternative Donor Transplantation for Lymphoid Malignancies: How Far We Have Come. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Editorial Article GET IT
Times cited: 1
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood advances. 2020 Academic Article GET IT
Times cited: 28
Combining haplo-identical and cord blood stem cell grafts - might the whole be greater than the sum of its parts?. Leukemia & lymphoma. 2020 Comment GET IT
Times cited: 1
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL. Blood advances. 2020 Academic Article GET IT
Times cited: 70
Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies. Journal of fungi (Basel, Switzerland). 2020 Academic Article GET IT
Times cited: 1100
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 9
Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient. Open forum infectious diseases. 2019 Academic Article GET IT
Times cited: 1
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 36
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Scientific reports. 2019 Academic Article GET IT
Times cited: 44
Donor graft genotypes versus leukemia. Leukemia & lymphoma. 2019 Comment GET IT
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood advances. 2019 Academic Article GET IT
Times cited: 23
Tocilizumab, in search for a role in acute GVHD. Leukemia & lymphoma. 2019 Comment GET IT
Times cited: 3
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma. Bone marrow transplantation. 2019 Academic Article GET IT
Times cited: 17
It's not all about the CNS. High dose methotrexate in DLBCL. Leukemia & lymphoma. 2019 Comment GET IT
Times cited: 1
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Review GET IT
Times cited: 15
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation. 2019 GET IT
Times cited: 18
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leukemia & lymphoma. 2019 Academic Article GET IT
Times cited: 23
The application of precision medicine in diagnosing familial Mediterranean fever. Leukemia & lymphoma. 2019 Letter GET IT
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant. Experimental hematology & oncology. 2019 Academic Article GET IT
Times cited: 175
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Academic Article GET IT
Times cited: 38
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 3
Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients. Bone marrow transplantation. 2018 Academic Article GET IT
Times cited: 30
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 11
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34⁺ hematopoietic progenitor cells in patients with sickle cell disease: interim results. Haematologica. 2018 Academic Article GET IT
Times cited: 6
A renaissance for autologous transplantation in follicular lymphoma?. Leukemia & lymphoma. 2018 Academic Article GET IT
Times cited: 1
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products. Leukemia & lymphoma. 2018 Academic Article GET IT
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34⁺ hematopoietic progenitor cells in patients with sickle cell disease: interim results. Haematologica. 2018 Academic Article GET IT
Times cited: 44
Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes. Journal of clinical pathology. 2018 Review GET IT
Times cited: 15
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review. Bone marrow transplantation. 2018 Academic Article GET IT
Times cited: 73
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 16
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience. Transfusion. 2017 Academic Article GET IT
Times cited: 2
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 23
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 12
Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors. Bone marrow transplantation. 2017 Academic Article GET IT
Times cited: 44
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. The Lancet. Haematology. 2017 Academic Article GET IT
Times cited: 117
Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplant. Leukemia & lymphoma. 2017 Comment GET IT
Times cited: 4
Against the odds: haplo-cord grafts protect from GvHD and relapse. Bone marrow transplantation. 2017 Comment GET IT
Times cited: 4
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data^. Leukemia & lymphoma. 2017 Letter GET IT
Times cited: 6
Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 29
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 8
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies. Transplantation. 2017 Academic Article GET IT
Times cited: 12
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Journal for immunotherapy of cancer. 2016 Academic Article GET IT
Times cited: 57
Second allogeneic transplantation: ever? never? or sometimes. Leukemia & lymphoma. 2016 Comment GET IT
Times cited: 1
Haplo-cord transplant: HLA-matching determines graft dominance. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 7
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 25
Haploidentical cord transplantation-The best of both worlds. Seminars in hematology. 2016 Review GET IT
Times cited: 20
HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disorders. Leukemia & lymphoma. 2016 Comment GET IT
Cord blood chimerism and relapse after haplo-cord transplantation. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 16
Clofarabine as a bridge to hematopoietic stem cell transplant. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 4
Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task. Bone marrow transplantation. 2016 Academic Article GET IT
Times cited: 5
Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Academic Article GET IT
Times cited: 19
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 67
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 11
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 47
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 16
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment. Clinical lymphoma, myeloma & leukemia. 2016 Academic Article GET IT
Times cited: 12
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. Haematologica. 2016 Academic Article GET IT
Times cited: 31
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation. Transfusion. 2015 Academic Article GET IT
Times cited: 7
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 12
Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2015 Academic Article GET IT
Times cited: 27
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone marrow transplantation. 2015 Academic Article GET IT
Times cited: 92
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration. Transfusion. 2015 Academic Article GET IT
Times cited: 12
Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells. Cytotherapy. 2015 Review GET IT
Times cited: 8
A new "age" for high dose therapy and autologous stem cell transplant. Leukemia & lymphoma. 2015 Comment GET IT
Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?. Current hematologic malignancy reports. 2015 Review GET IT
Times cited: 10
Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned. Leukemia & lymphoma. 2015 Comment GET IT
Times cited: 5
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions. Transfusion. 2015 Academic Article GET IT
Times cited: 17
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 10
Controversies in multiple myeloma: to transplant or not?. Current hematologic malignancy reports. 2014 Review GET IT
Times cited: 2
Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clinical advances in hematology & oncology : H&O. 2014 Review GET IT
Times cited: 37
Advances in umbilical cord blood transplant: an overview of the 12th International Cord Blood Symposium, San Francisco, 5-7 June 2014. Leukemia & lymphoma. 2014 Conference Paper GET IT
Statement of Retraction: Huang H, Wu D, Fu J, Chen G. "multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid". Leukemia & lymphoma. 2014 Article GET IT
To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?. Leukemia & lymphoma. 2014 Letter GET IT
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 14
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica. 2014 Academic Article GET IT
Times cited: 165
Advances in umbilical cord blood transplant: a summary of the 11th International Cord Blood Symposium, San Francisco, 6-8 June 2013. Leukemia & lymphoma. 2014 Conference Paper GET IT
Times cited: 5
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 27
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 31
Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphoma. Leukemia & lymphoma. 2014 Comment GET IT
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation. Bone marrow transplantation. 2014 Letter GET IT
Times cited: 17
Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection. Chimerism. 2014 Review GET IT
Times cited: 34
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 97
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood. 2013 Academic Article GET IT
Times cited: 124
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas. British journal of haematology. 2013 Academic Article GET IT
Times cited: 41
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 162
Statement of retraction. Avilés A, Fernándezb R, Pérez F, Nambo MJ, Neri N, Talavera A, Castañeda C,González M, Cleto. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome. Leukemia & lymphoma. 2013 Article GET IT
Times cited: 2
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Bone marrow transplantation. 2013 Academic Article GET IT
Times cited: 20
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 14
Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation. Case reports in hematology. 2013 Academic Article GET IT
Microchimerism and allogeneic transplantation: we need the proof in the pudding. Chimerism. 2013 Academic Article GET IT
Times cited: 1
Immune reconstitution after combined haploidentical and umbilical cord blood transplant. Leukemia & lymphoma. 2013 Academic Article GET IT
Times cited: 23
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 30
Peripheral-blood versus bone marrow stem cells. The New England journal of medicine. 2013 Letter GET IT
Times cited: 6
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas. Cancer. 2013 Academic Article GET IT
Times cited: 6
Pre-transplant serum ferritin is prognostic but is it useful?. Leukemia & lymphoma. 2013 Comment GET IT
Times cited: 2
Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. Hematology. American Society of Hematology. Education Program. 2013 Review GET IT
Times cited: 32
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia. Blood. 2012 Letter GET IT
Times cited: 14
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Academic Article GET IT
Times cited: 82
Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors. Cytokine. 2012 Academic Article GET IT
Times cited: 7
Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Review GET IT
Times cited: 31
cGVHD of skin: simple tools, great advances. Blood. 2012 Comment GET IT
Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications. Leukemia & lymphoma. 2012 Letter GET IT
Times cited: 3
Therapeutic drug monitoring: a way to improve long-term immunological balance?. Leukemia & lymphoma. 2012 Comment GET IT
Addition of plerixafor to mobilization regimens in autologous peripheral blood stem cell transplants does not affect the correlation of preharvest hematopoietic precursor cell enumeration with first-harvest CD34+ stem cell yield. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Academic Article GET IT
Times cited: 12
Lenalidomide after stem-cell transplantation for multiple myeloma. The New England journal of medicine. 2012 Academic Article GET IT
Times cited: 931
Influence of related donor age on outcomes after peripheral blood stem cell transplantation. Cytotherapy. 2012 Academic Article GET IT
Times cited: 12
Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis. Bone marrow transplantation. 2012 Academic Article GET IT
Times cited: 16
Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 21
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 17
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 20
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 31
Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. Current opinion in oncology. 2011 Review GET IT
Times cited: 16
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011 Academic Article GET IT
Times cited: 141
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era. Hematology/oncology clinics of North America. 2011 Review GET IT
Times cited: 11
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leukemia & lymphoma. 2011 Review GET IT
Times cited: 16
Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity. Leukemia & lymphoma. 2011 Letter GET IT
Times cited: 8
Stem cell transplantation for indolent lymphoma: a reappraisal. Blood reviews. 2011 Review GET IT
Times cited: 2
Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions. Leukemia & lymphoma. 2011 Comment GET IT
Alemtuzumab in allogeneic hematopoetic stem cell transplantation. Expert opinion on biological therapy. 2011 Academic Article GET IT
Times cited: 28
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 98
Cord blood transplant: the glass is half full--can we do better?. Leukemia & lymphoma. 2011 Comment GET IT
Times cited: 4
Personalized treatment of lymphoma: promise and reality. Seminars in oncology. 2011 Review GET IT
Times cited: 10
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation. Bone marrow transplantation. 2011 Academic Article GET IT
Times cited: 30
T-cell-depleted reduced-intensity conditioning transplantation for lymphoma: do donor lymphocyte infusions really matter?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Letter GET IT
Times cited: 1
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 36
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse. Leukemia & lymphoma. 2010 Academic Article GET IT
Times cited: 11
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. Leukemia & lymphoma. 2010 Academic Article GET IT
Times cited: 27
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 162
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2010 Academic Article GET IT
Times cited: 110
Donor policies for stem cell transplantation. JAMA. 2010 Letter GET IT
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leukemia & lymphoma. 2010 Academic Article GET IT
Times cited: 12
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2010 Academic Article GET IT
Times cited: 24
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant. Leukemia & lymphoma. 2010 Academic Article GET IT
Times cited: 14
The next frontier for stem cell transplantation: finding a donor for all. JAMA. 2010 Academic Article GET IT
Times cited: 12
Stem-cell transplantation for sickle cell disease. The New England journal of medicine. 2010 Letter GET IT
Times cited: 4
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML. Bone marrow transplantation. 2010 Academic Article GET IT
Times cited: 20
Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2010 Editorial Article GET IT
Times cited: 21
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2010 Review GET IT
Times cited: 50
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 246
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation. 2009 Academic Article GET IT
Times cited: 38
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 48
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leukemia & lymphoma. 2009 Academic Article GET IT
Times cited: 47
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 70
Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 46
Advances in mobilization for the optimization of autologous stem cell transplantation. Leukemia & lymphoma. 2009 Review GET IT
Times cited: 44
Fatal CMV pneumonitis in a lymphoma patient treated with rituximab. American journal of hematology. 2009 Letter GET IT
Times cited: 9
Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 4
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 73
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 48
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 28
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood. 2009 Academic Article GET IT
Times cited: 125
Autologous transplant for primary mediastinal B-cell lymphoma. Expert review of hematology. 2009 Comment GET IT
Times cited: 4
Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy. Hematology. American Society of Hematology. Education Program. 2009 Review GET IT
Times cited: 18
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia. Leukemia & lymphoma. 2009 Academic Article GET IT
Times cited: 10
Reduced-intensity and nonmyeloablative conditioning regimens. Cancer treatment and research. 2009 Review GET IT
Times cited: 3
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 91
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 35
Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infection control and hospital epidemiology. 2008 Academic Article GET IT
Times cited: 24
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 68
Happy anniversary to the 10th ICML--International Conference on Malignant Lymphoma in Lugano, 4-7 June 2008With a personal tribute to the conference president and founder of ICML--Professor Franco Cavalli. Leukemia & lymphoma. 2008 Editorial Article GET IT
Nonmyeloablative conditioning for relapsed follicular lymphoma. Blood. 2008 Letter GET IT
Times cited: 1
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?. Leukemia & lymphoma. 2008 Comment GET IT
Superiority of reduced-intensity conditioning for Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Letter GET IT
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 54
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 46
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood. 2008 Academic Article GET IT
Times cited: 281
Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease. 2008 GET IT
Times cited: 13
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products. Leukemia & lymphoma. 2008 Academic Article GET IT
Times cited: 8
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 138
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. The Journal of biological chemistry. 2008 Academic Article GET IT
Times cited: 35
Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment. Leukemia & lymphoma. 2008 Review GET IT
Times cited: 36
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance. Bone marrow transplantation. 2007 Review GET IT
Times cited: 42
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone marrow transplantation. 2007 Academic Article GET IT
Times cited: 64
Successful allogeneic transplantation of patients with suspected prior invasive mold infection. Leukemia & lymphoma. 2007 Academic Article GET IT
Times cited: 12
Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone marrow transplantation. 2007 Letter GET IT
Times cited: 7
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 229
Cardiac tamponade in a patient with chronic lymphocytic leukemia. Leukemia & lymphoma. 2007 Letter GET IT
Times cited: 2
Interdigitating dendritic cell tumors in two patients exposed to topical calcineurin inhibitors. Leukemia & lymphoma. 2007 Letter GET IT
Times cited: 14
Follicular lymphoma: a historical overview. Leukemia & lymphoma. 2007 Academic Article GET IT
Times cited: 8
An introduction to foundation and industry-sponsored research: practical and ethical considerations. Hematology. American Society of Hematology. Education Program. 2007 Academic Article GET IT
Times cited: 3
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2006 Academic Article GET IT
Times cited: 102
Severe intestinal graft-versus-host disease following autologous stem cell transplantation. Bone marrow transplantation. 2006 Letter GET IT
Times cited: 7
Standardizing chronic graft-versus-host disease. Future oncology (London, England). 2006 Review GET IT
Times cited: 4
Toxicity of high dose BCNU: how much is too much?. Leukemia & lymphoma. 2006 Comment GET IT
Times cited: 3
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood. 2006 Academic Article GET IT
Times cited: 205
Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncology nursing forum. 2006 Academic Article GET IT
Times cited: 106
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. 2006 GET IT
Times cited: 42
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2006 Academic Article GET IT
Times cited: 72
The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma. Blood reviews. 2006 Review GET IT
Times cited: 20
Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation. British journal of haematology. 2006 Review GET IT
Times cited: 6
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning. Bone marrow transplantation. 2006 Academic Article GET IT
Times cited: 43
Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2005 Academic Article GET IT
Times cited: 10
Hematopoietic stem cell transplantation for myelofibrosis. Seminars in oncology. 2005 Review GET IT
Times cited: 12
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 121
Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant. Current treatment options in oncology. 2005 Review GET IT
Times cited: 2
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes. Bone marrow transplantation. 2005 Academic Article GET IT
Times cited: 50
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer research. 2005 Academic Article GET IT
Times cited: 89
Arterial thrombosis in four patients treated with thalidomide. 2005 GET IT
Times cited: 41
Autologous and allogeneic stem cell transplantation in follicular lymphoma. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2005 Review GET IT
Times cited: 2
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience. Bone marrow transplantation. 2005 Academic Article GET IT
Times cited: 40
Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?. Leukemia. 2005 Comment GET IT
Times cited: 16
Stem cell transplantation in follicular lymphoma: progress at last?. Bone marrow transplantation. 2004 Review GET IT
Times cited: 22
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood. 2004 Academic Article GET IT
Times cited: 99
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection. Blood. 2004 Letter GET IT
Times cited: 6
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2004 Academic Article GET IT
Times cited: 10
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma. Bone marrow transplantation. 2004 Academic Article GET IT
Times cited: 39
Low-grade lymphoma. Hematology. American Society of Hematology. Education Program. 2004 Review GET IT
Times cited: 51
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 136
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. Bone marrow transplantation. 2003 Academic Article GET IT
Times cited: 44
Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship. 2003 GET IT
Times cited: 8
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003 Academic Article GET IT
Times cited: 311
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies. Bone marrow transplantation. 2003 Academic Article GET IT
Times cited: 6
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir. Bone marrow transplantation. 2003 Academic Article GET IT
Times cited: 15
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias. Cancer. 2003 Academic Article GET IT
Times cited: 42
Clinical activity of arsenic trioxide in Burkitt-like lymphoma. Leukemia. 2003 Letter GET IT
Times cited: 14
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2002 Academic Article GET IT
Times cited: 126
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway. Biochemical and biophysical research communications. 2002 Academic Article GET IT
Times cited: 37
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia. Journal of immunology (Baltimore, Md. : 1950). 2002 Academic Article GET IT
Times cited: 88
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma. Blood. 2002 Letter GET IT
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood. 2002 Academic Article GET IT
Times cited: 122
Autologous and allogeneic transplantation for aggressive NHL. Cytotherapy. 2002 Review GET IT
Times cited: 14
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 2001 Academic Article GET IT
Times cited: 173
Allogeneic and autologous transplantation for chronic lymphocytic leukemia. Leukemia. 2001 Review GET IT
Times cited: 29
Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone marrow transplantation. 2001 Academic Article GET IT
Times cited: 63
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant. Bone marrow transplantation. 2001 Academic Article GET IT
Times cited: 31
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia. American journal of hematology. 2001 Academic Article GET IT
Times cited: 21
Primary mediastinal B-cell lymphoma: a review of pathology and management. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Review GET IT
Times cited: 123
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone marrow transplantation. 2001 Academic Article GET IT
Times cited: 105
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival. Bone marrow transplantation. 2001 Academic Article GET IT
Times cited: 11
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 29
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 188
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. 2000 GET IT
Times cited: 86
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant. Bone marrow transplantation. 2000 Academic Article GET IT
Times cited: 8
Allogeneic transplantation for low-grade lymphoma: long-term follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Letter GET IT
Times cited: 13
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2000 Academic Article GET IT
Times cited: 21
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma. Leukemia & lymphoma. 1999 Academic Article GET IT
Times cited: 16
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone marrow transplantation. 1999 Academic Article GET IT
Times cited: 62
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999 Academic Article GET IT
Times cited: 194
Toxicity of single daily dose gentamicin in stem cell transplantation. Bone marrow transplantation. 1999 Academic Article GET IT
Times cited: 10
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 1999 Academic Article GET IT
Times cited: 44
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia. Bone marrow transplantation. 1999 Academic Article GET IT
Times cited: 20
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 179
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1999 Academic Article GET IT
Times cited: 21
Allogeneic bone marrow transplantation for low-grade lymphoma. Blood. 1998 Academic Article GET IT
Times cited: 239
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 223
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood. 1998 Academic Article GET IT
Times cited: 267
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 59
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells. The cancer journal from Scientific American. 1997 Academic Article GET IT
Times cited: 12
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 21
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1997 Academic Article GET IT
Times cited: 22
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997 Academic Article GET IT
Times cited: 1068
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology. 1997 Review GET IT
Times cited: 19
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1997 Academic Article GET IT
Times cited: 31
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. British journal of haematology. 1997 Academic Article GET IT
Times cited: 94
Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization. Leukemia & lymphoma. 1997 Academic Article GET IT
Times cited: 14
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. 1997 GET IT
Times cited: 37
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. 1997 GET IT
Times cited: 202
Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 81
Studies of decitabine with allogeneic progenitor cell transplantation. Leukemia. 1997 Academic Article GET IT
Times cited: 20
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 41
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 64
Invasive Aspergillus sinusitis during bone marrow transplantation. 1997 GET IT
Times cited: 20
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature. European journal of gynaecological oncology. 1997 Review GET IT
Times cited: 19
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. Transplantation. 1996 Academic Article GET IT
Times cited: 42
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood. 1996 Academic Article GET IT
Times cited: 119
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors. Bone marrow transplantation. 1996 Academic Article GET IT
Times cited: 35
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 34
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology. The American journal of medicine. 1996 Academic Article GET IT
Times cited: 105
Autologous bone marrow transplantation for leukemia and lymphoma. Cancer treatment and research. 1996 Review GET IT
Times cited: 2
Treatment of relapse after allogeneic bone marrow transplantation. Cancer treatment and research. 1996 Review GET IT
Times cited: 3
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 1995 Academic Article GET IT
Times cited: 307
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 1995 Academic Article GET IT
Times cited: 36
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995 Academic Article GET IT
Times cited: 290
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation. Cytokines and molecular therapy. 1995 Academic Article GET IT
Times cited: 12
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 107
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. Bone marrow transplantation. 1995 Academic Article GET IT
Times cited: 57
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood. 1995 Academic Article GET IT
Times cited: 578
High-dose melphalan allows durable engraftment of allogeneic bone marrow. 1995 GET IT
Times cited: 24
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation. Bone marrow transplantation. 1995 Academic Article GET IT
Times cited: 47
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 47
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 176
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone marrow transplantation. 1994 Academic Article GET IT
Times cited: 41
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood. 1993 Academic Article GET IT
Times cited: 125
Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. 1992 GET IT
Times cited: 36
Is interleukin 6 the physiological regulator of thrombopoiesis?. Experimental hematology. 1992 Academic Article GET IT
Times cited: 23
Pregnancy-associated aplastic anemia--report of 3 cases. 1991 GET IT
Times cited: 21
Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid. 1991 GET IT
Times cited: 28
Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood cells. 1991 Review GET IT
Times cited: 125
Simultaneous use of rhodamine 123, phycoerythrin, Texas red, and allophycocyanin for the isolation of human hematopoietic progenitor cells. Cytometry. 1991 Academic Article GET IT
Times cited: 33
Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood. 1990 Academic Article GET IT
Times cited: 145
Preleukemic state preceding adult acute lymphoblastic leukemia. 1990 GET IT
Times cited: 3
Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. The Journal of clinical investigation. 1990 Academic Article GET IT
Times cited: 128
Characteristics of engraftment after repeated autologous bone marrow transplantation. Experimental hematology. 1990 Academic Article GET IT
Times cited: 5
Characterization of human hematopoietic stem cells. Progress in clinical and biological research. 1990 Academic Article GET IT
Times cited: 8
Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor. 1989 GET IT
Times cited: 40
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1989 Academic Article GET IT
Times cited: 333
Endoscopic sclerotherapy of esophageal varices. Long-term follow-up, recurrence, and survival. Journal of clinical gastroenterology. 1988 Academic Article GET IT
Times cited: 12

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

CAR T Cells for Advanced Thyroid Cancer awarded by National Cancer Institute Key Personnel 2021 - 2026

more ...

less ...

Background

education and training

Ph.D., University of Maastricht Faculty of Health, Medicine and Life Sciences (Netherlands) 2006
Ph.D., University of Maastricht (Netherlands) 2006
M.D., Catholic University of Louvain, Faculty of Medicine (Belgium) 1984

VIVO Weill Cornell Medical College

Koen Van Besien Adjunct Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email